Will Late Loss Debate Stifle Device Start-Up Innovation?
This article was originally published in Start Up
Executive Summary
The failure of Medtronic's Endeavor stent to hit its primary clinical trial endpoint has again spurred debate over surrogate endpoints, a potentially big issue for small companies.
You may also be interested in...
The Double-edged Sword of Diabetes Drug Development
Intense interest in new diabetes drugs gives start-ups many choices for technology development or in-licensing, but recent regulatory caution also increases risk.
View From the Cath Lab: Hot Issues in Cardiology
Three leading interventional cardiologists provide international perspectives on the most important issues confronting their specialty and how they will impact the device industry.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.